Literature DB >> 15099615

Factorial structure of the Scale of Prodromal Symptoms.

K A Hawkins1, T H McGlashan, D Quinlan, T J Miller, D O Perkins, R B Zipursky, J Addington, S W Woods.   

Abstract

Data from the Scale of Prodromal Symptoms (SOPS) [Early Intervention in Psychotic Disorders, pp. 135-150] on 94 hitherto never-psychotic individuals were entered into a principal components analysis, revealing six components with an eigenvalue greater than 1.0. Based upon scree-plot analysis, further extractions were limited to three, then two, factors. Varimax rotation of the three-component extraction revealed factors with reasonable congruence with a priori content areas. All symptoms labeled as negative in the SOPS loaded on one factor, and four of five symptoms labeled as positive loaded on another. The remaining positive symptom, conceptual disorganization, has been found not to load with other positive-labeled symptoms in studies of schizophrenia using applicable instruments. All symptoms labeled as "general" in the SOPS loaded on a third factor, which appears to reflect the nonspecific psychological distress that might be expected in psychosis-naïve individuals experiencing the preliminary stages of a serious psychiatric disorder. The independence of this component from the positive and negative symptom factors suggests that the structure obtained suggests a clinical continuity between the at-risk presentations seen in this sample and established schizophrenia.

Entities:  

Mesh:

Year:  2004        PMID: 15099615     DOI: 10.1016/S0920-9964(03)00053-7

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  45 in total

1.  Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis.

Authors:  Lawrence H Yang; Bruce G Link; Shelly Ben-David; Kelly E Gill; Ragy R Girgis; Gary Brucato; Ahtoy J Wonpat-Borja; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2015-08-25       Impact factor: 4.939

2.  Subthreshold psychotic symptoms in 22q11.2 deletion syndrome.

Authors:  Sunny X Tang; James J Yi; Tyler M Moore; Monica E Calkins; Christian G Kohler; Daneen A Whinna; Margaret C Souders; Elaine H Zackai; Donna M McDonald-McGinn; Beverly S Emanuel; Warren B Bilker; Ruben C Gur; Raquel E Gur
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-19       Impact factor: 8.829

3.  Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders.

Authors:  Sarah I Tarbox; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Robert Heinssen; Thomas H McGlashan; Scott W Woods
Journal:  Psychiatry Res       Date:  2013-10-18       Impact factor: 3.222

4.  Factor Analysis of Negative Symptom Items in the Structured Interview for Prodromal Syndromes.

Authors:  Matilda Azis; Gregory P Strauss; Elaine Walker; William Revelle; Richard Zinbarg; Vijay Mittal
Journal:  Schizophr Bull       Date:  2019-09-11       Impact factor: 9.306

5.  Subclinical expression of schizophrenia-like symptoms in non-psychotic siblings of individuals with schizophrenia.

Authors:  Matthew J Smith; Deanna M Barch; Paul A Thompson; John G Csernansky
Journal:  Schizophr Res       Date:  2008-06-11       Impact factor: 4.939

6.  Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial.

Authors:  David J Miklowitz; Mary P O'Brien; Danielle A Schlosser; Jean Addington; Kristin A Candan; Catherine Marshall; Isabel Domingues; Barbara C Walsh; Jamie L Zinberg; Sandra D De Silva; Michelle Friedman-Yakoobian; Tyrone D Cannon
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-06-02       Impact factor: 8.829

7.  Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.

Authors:  Cheryl M Corcoran; David Kimhy; Arielle Stanford; Shamir Khan; Julie Walsh; Judy Thompson; Scott Schobel; Jill Harkavy-Friedman; Ray Goetz; Tiziano Colibazzi; Victoria Cressman; Dolores Malaspina
Journal:  Schizophr Res       Date:  2008-09-21       Impact factor: 4.939

8.  Progress in the Prospective Study of the Schizophrenia Prodrome.

Authors:  Emery J Fu; Kristin S Cadenhead
Journal:  Curr Psychos Ther Rep       Date:  2005-12-01

9.  MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms.

Authors:  Beng-Choon Ho
Journal:  Schizophr Res       Date:  2007-08-29       Impact factor: 4.939

10.  Associations between psychotic-like symptoms and inattention/hyperactivity symptoms.

Authors:  Tuula Marketta Hurtig; Anja Taanila; Juha Veijola; Hanna Ebeling; Pirjo Mäki; Jouko Miettunen; Marika Kaakinen; Matti Joukamaa; Sebastian Therman; Markus Heinimaa; Marjo-Riitta Järvelin; Irma Moilanen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-11-12       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.